Best Seller What you get: Unlimited access to articles Get all four HHP monthly newsletters straight to your inbox Subscriber-only articles Full access to A to Z comprehensive library Quizzes, health tips and more
However, the use of excessive dosages in patients with no deficiency is discouraged
Read the interview here:Pharmacy Times Interview on TRIUMPH-1 Results #ADA2026 #ScientificSessions #ObesityMedicine #DiabetesCare #CardiometabolicHealth #Retatrutide #GLP1 #IncretinTherapy #ClinicalPharmacy #Pharmacists Massachusetts College of Pharmacy and Health Sciences School of Pharmacy-Boston, Massachusetts College of Pharmacy and Health Sciences To view or add a comment, sign in More Relevant Posts Recent reports have raised concerns about a possible link between GLP-1 medications such as Wegovy and Ozempic and the rare eye condition Nonarteritic Anterior Ischemic Optic Neuropathy, which can cause sudden vision loss
It is generally not recommended to stop GLP-1 therapy abruptly unless under strict medical supervision
We'll be watching, and we'll report back, so please stay tuned.
Bioactives of fruiting bodies and submerged culture mycelia of Agaricus brasiliensis ( A